Literature DB >> 10772045

Mitral regurgitation following percutaneous transvenous mitral commissurotomy: a single-center experience.

U A Kaul1, S Singh, G S Kalra, M Nair, J C Mohan, M Nigam, R Arora.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Percutaneous transvenous mitral commissurotomy (PTMC) has revolutionized the treatment of patients with symptomatic mitral stenosis and is now established as the procedure of choice. Despite high technical expertise in PTMC using the Inoue balloon, mitral regurgitation (MR) remains a major procedure-related complication. We retrospectively analyzed our data of PTMC using the Inoue balloon with regard to the incidence of MR, its likely causative mechanism, and follow up of these patients.
METHODS: During the past ten years, PTMC was performed in 3,650 patients (median age 26 years; range: 8-76 years), of whom 910 (24.9%) were juveniles. Preprocedure mitral valve area (MVA) was 0.9 +/- 0.4 cm2 (range: 0.3-1.3 cm2); MR was mild in 1,396 cases (38.2%), moderate in 394 (10.8%) and severe in 22 (0.6%). None of the patients was rejected on the basis of echocardiographic score.
RESULTS: The procedure was successful in 3,276 (89.8%), with post-procedure MVA of 1.7 +/- 0.6 cm2 (range: 1.4-2.6 cm2), and without development of any major complication. Severe MR was seen in 120 patients (3.3%), of whom 66 (1.8%) required urgent mitral valve replacement (MVR). Echocardiography in these latter patients showed leaflet rupture in 48 (72.7%), chordal rupture in 12 (18.2%) and excessive commissural tear in six (9.1%). Fifty-four patients (1.5%) with severe MR post PTMC were followed with medical treatment; echocardiography in these patients revealed chordal rupture in 40 (74.1%) and excessive commissural tear in 14 (25.9%). Follow up data were available in 49 patients (1.3%); 30 (0.8%) required MVR and 19 (0.5%) were in NYHA class II at a median follow up of 24 months. Moderate MR was seen in 188 cases (5.1%), with predominant causative mechanisms of excessive commissural tear in 120 (63.8%) and chordal rupture in 68 (36.2%). Severity of MR worsened in 30 cases (0.8%), of which 20 (0.6%) required elective MVR on follow up. MR decreased in 58 patients (1.6%), in whom excessive commissural tear was the causative mechanism.
CONCLUSION: Significant MR (moderate or severe) after PTMC was seen in 308 patients (8.4%), of whom 116 (3.2%) required MVR urgently or on follow up. All patients with leaflet rupture during PTMC developed severe MR and required urgent MVR. There was a tendency for the severity of MR to decrease with time in cases where excessive commissural tear was the causative mechanism.

Entities:  

Mesh:

Year:  2000        PMID: 10772045

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  10 in total

1.  Percutaneous transvenous mitral commissurotomy in elderly mitral stenosis patients. A retrospective study at shahid gangalal national heart centre, bansbari, kathmandu, Nepal.

Authors:  Chandra Mani Adhikari; Rabi Malla; Rajib Rajbhandari; Yadav Kumar Bhatta; Arun Maskey; Suman Thapaliya; Prakash Gurung; Kc Man Bahadur
Journal:  Maedica (Buchar)       Date:  2013-09

Review 2.  Role of CT and MRI in Cardiac Emergencies.

Authors:  Carlo Liguori; Stefania Tamburrini; Giovanni Ferrandino; Silvio Leboffe; Nicola Rosano; Ines Marano
Journal:  Tomography       Date:  2022-05-23

3.  Mechanism and Immediate Outcome of Significant Mitral Regurgitation Following Balloon Mitral Valvuloplasty with JOMIVA Balloon.

Authors:  Shanmuga Sundaram; Tamilarasu Kaliappan; Rajendiran Gopalan; Ramasamy Palanimuthu; Premkrishna Anandhan; Rinku Mary Joseph
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Mitral Regurgitation After Percutaneous Mitral Valvuloplasty: Insights Into Mechanisms and Impact on Clinical Outcomes.

Authors:  Maria Carmo P Nunes; Robert A Levine; Renato Braulio; Marcelo A Pascoal-Xavier; Sammy Elmariah; Nayana F A Gomes; Juliana R Soares; William A M Esteves; Xin Zeng; Jacob P Dal-Bianco; Livia S A Passos; Luiz G Passaglia; Victor T Ribeiro; Cláudio L Gelape; Paulo H N Costa; Lucas Lodi-Junqueira; Walderez Dutra; Timothy C Tan; Elena Aikawa; Judy Hung
Journal:  JACC Cardiovasc Imaging       Date:  2020-09-16

5.  Predictors of developing significant mitral regurgitation following percutaneous mitral commissurotomy with inoue balloon technique.

Authors:  Abdelfatah A Elasfar; Hatem F Elsokkary
Journal:  Cardiol Res Pract       Date:  2011-08-15       Impact factor: 1.866

6.  Mitral regurgitation after percutaneous balloon mitral valvotomy in patients with rheumatic mitral stenosis: a single-center study.

Authors:  Naser Aslanabadi; Mehrnoush Toufan; Rezvaneyeh Salehi; Azin Alizadehasl; Samad Ghaffari; Bahram Sohrabi; Ahmad Separham; Ataolaah Manafi; Mohammad Bagher Mehdizadeh; Afshin Habibzadeh
Journal:  J Tehran Heart Cent       Date:  2014-07-03

7.  Safety and efficacy of percutaneous balloon mitral valvotomy in severe mitral stenosis with moderate mitral regurgitation - A prospective study.

Authors:  Vinayakumar Desabandhu; Nithin Gopalan Peringadan; Mangalath Narayanan Krishnan
Journal:  Indian Heart J       Date:  2016-05-16

8.  Proinflammatory Matrix Metalloproteinase-1 Associates With Mitral Valve Leaflet Disruption Following Percutaneous Mitral Valvuloplasty.

Authors:  Livia S A Passos; Dakota Becker-Greene; Renato Braulio; Thanh-Dat Le; Cláudio L Gelape; Luís Felipe R de Almeida; Divino Pedro A Rocha; Carlos Augusto P Gomes; William A M Esteves; Luiz G Passaglia; Jacob P Dal-Bianco; Robert A Levine; Masanori Aikawa; Judy Hung; Walderez O Dutra; Maria Carmo P Nunes; Elena Aikawa
Journal:  Front Cardiovasc Med       Date:  2022-01-20

9.  Comparison of two different techniques for balloon sizing in percutaneous mitral balloon valvuloplasty: which is preferable?

Authors:  Ahmet Tastan; Ali Ozturk; Omer Senarslan; Erdem Ozel; Samet Uyar; Emin Evren Ozcan; Omer Kozan
Journal:  Cardiovasc J Afr       Date:  2016-01-26       Impact factor: 1.167

10.  Immediate and long-term outcomes of balloon mitral valvotomy in pregnancy.

Authors:  Krishnarpan Chatterjee; Roopali Khanna; Ankit Sahu; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Aditya Kapoor; Pravin K Goel
Journal:  Indian Heart J       Date:  2020-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.